Published in Angew Chem Int Ed Engl on January 01, 2007
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater (2008) 4.81
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res (2010) 2.70
Toxicity of nanomaterials. Chem Soc Rev (2011) 2.07
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine (2008) 1.99
Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug Chem (2010) 1.85
A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol (2009) 1.85
Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ Sci Technol (2010) 1.84
Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol (2008) 1.79
The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci (2010) 1.71
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release (2013) 1.64
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology (2013) 1.57
Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51
Nano meets biology: structure and function at the nanoparticle interface. Langmuir (2011) 1.43
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34
Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J R Soc Interface (2009) 1.31
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm (2010) 1.29
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Urban air pollution: influences on olfactory function and pathology in exposed children and young adults. Exp Toxicol Pathol (2009) 1.23
Design of synthetic polymer nanoparticles that capture and neutralize a toxic peptide. Small (2009) 1.21
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci (2013) 1.16
On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol (2009) 1.13
New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface (2013) 1.09
The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology (2010) 1.08
Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev (2014) 1.07
Models for oral uptake of nanoparticles in consumer products. Toxicology (2011) 1.07
Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Rep (2014) 1.06
Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size. Proteomics (2011) 1.06
Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology (2011) 1.03
Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res (2012) 1.00
Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res (2014) 0.99
Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part Fibre Toxicol (2013) 0.98
In situ measurement of bovine serum albumin interaction with gold nanospheres. Langmuir (2012) 0.98
Synthetic polymer nanoparticle-polysaccharide interactions: a systematic study. J Am Chem Soc (2012) 0.96
Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B (2012) 0.92
Cellular Binding of Anionic Nanoparticles is Inhibited by Serum Proteins Independent of Nanoparticle Composition. Biomater Sci (2013) 0.91
Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids. PLoS One (2013) 0.91
Effect of nanoparticles on protein folding and fibrillogenesis. Int J Mol Sci (2009) 0.90
25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine. Adv Mater (2013) 0.90
Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. ACS Nano (2012) 0.90
Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One (2011) 0.90
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet (2011) 0.90
Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc (2014) 0.89
Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J Phys Chem B (2014) 0.89
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles. Biomaterials (2014) 0.89
The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. Small (2012) 0.89
Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol (2016) 0.87
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) (2015) 0.86
Gold- and silver nanoparticles affect the growth characteristics of human embryonic neural precursor cells. PLoS One (2013) 0.86
Temperature-responsive "catch and release" of proteins by using multifunctional polymer-based nanoparticles. Angew Chem Int Ed Engl (2012) 0.85
Inorganic Nanoparticles for Therapeutic Delivery: Trials, Tribulations and Promise. Curr Opin Colloid Interface Sci (2014) 0.85
Analytical strategies for detecting nanoparticle-protein interactions. Analyst (2010) 0.85
Precise quantification of nanoparticle internalization. ACS Nano (2013) 0.85
Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles. Environ Sci Nano (2015) 0.83
Protein corona - from molecular adsorption to physiological complexity. Beilstein J Nanotechnol (2015) 0.82
Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes. Sensors (Basel) (2012) 0.82
Gold nanoprobes for theranostics. Nanomedicine (Lond) (2011) 0.82
Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep (2015) 0.81
Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. Nanomedicine (2014) 0.81
Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics. ACS Nano (2013) 0.81
Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett (2015) 0.81
Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles. PLoS One (2012) 0.81
Food chain transport of nanoparticles affects behaviour and fat metabolism in fish. PLoS One (2012) 0.81
Combination of small size and carboxyl functionalisation causes cytotoxicity of short carbon nanotubes. Nanotoxicology (2012) 0.81
Dispersion Behaviour of Silica Nanoparticles in Biological Media and Its Influence on Cellular Uptake. PLoS One (2015) 0.80
Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate. Int J Nanomedicine (2014) 0.80
PEG-stabilized core-shell surface-imprinted nanoparticles. Langmuir (2013) 0.80
Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities. Biotechnol Adv (2013) 0.80
Aggregated gas molecules: toxic to protein? Sci Rep (2013) 0.80
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem (2014) 0.80
Analysis of SiO2 nanoparticles binding proteins in rat blood and brain homogenate. Int J Nanomedicine (2014) 0.79
Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles. ACS Chem Neurosci (2012) 0.78
Effects of naked gold nanoparticles on proinflammatory cytokines mRNA expression in rat liver and kidney. Biomed Res Int (2013) 0.78
Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma. Cell Mol Immunol (2015) 0.78
Spherical nucleic acid nanoparticle conjugates enhance G-quadruplex formation and increase serum protein interactions. Angew Chem Int Ed Engl (2014) 0.78
Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomedicine (2015) 0.78
Adsorption and Unfolding of a Single Protein Triggers Nanoparticle Aggregation. ACS Nano (2016) 0.78
Vitronectin absorbed on nanoparticles mediate cell viability/proliferation and uptake by 3T3 Swiss albino mouse fibroblasts: in vitro study. Biomed Res Int (2013) 0.77
Preparation of Core-Shell Hybrid Materials by Producing a Protein Corona Around Magnetic Nanoparticles. Nanoscale Res Lett (2015) 0.77
Electrostatic Interactions and Protein Competition Reveal a Dynamic Surface in Gold Nanoparticle-Protein Adsorption. J Phys Chem C Nanomater Interfaces (2016) 0.77
Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona. ACS Appl Mater Interfaces (2014) 0.76
A centrifugation-based physicochemical characterization method for the interaction between proteins and nanoparticles. Nat Commun (2016) 0.76
Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages. PLoS One (2015) 0.76
Negatively charged metal oxide nanoparticles interact with the 20S proteasome and differentially modulate its biologic functional effects. ACS Nano (2013) 0.76
Toward a molecular understanding of nanoparticle-protein interactions. Biophys Rev (2012) 0.76
Characterisation of the protein corona using tunable resistive pulse sensing: determining the change and distribution of a particle's surface charge. Anal Bioanal Chem (2016) 0.75
The nanoparticle protein corona formed in human blood or human blood fractions. PLoS One (2017) 0.75
The effect of the serum corona on interactions between a single nano-object and a living cell. Sci Rep (2017) 0.75
Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles. Nanomaterials (Basel) (2015) 0.75
Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition. Int J Nanomedicine (2015) 0.75
Recent progress on magnetic nanoparticles for magnetic hyperthermia. Prog Biomater (2016) 0.75
Inorganic Janus particles for biomedical applications. Beilstein J Nanotechnol (2014) 0.75
Direct deposition of gas phase generated aerosol gold nanoparticles into biological fluids--corona formation and particle size shifts. PLoS One (2013) 0.75
Nanomedicines for renal disease: current status and future applications. Nat Rev Nephrol (2016) 0.75
Methods for the In Vitro Characterization of Nanomedicines-Biological Component Interaction. J Pers Med (2017) 0.75
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine (2017) 0.75
Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application. Int J Nanomedicine (2016) 0.75
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature (2006) 24.29
Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments. Brief Bioinform (2007) 8.26
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol (2003) 6.79
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach. Mol Cell Biol (2002) 5.04
Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell (2005) 4.95
Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog (2009) 4.24
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
High-definition macromolecular composition of yeast RNA-processing complexes. Mol Cell (2004) 4.18
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
Functional organization of the S. cerevisiae phosphorylation network. Cell (2009) 3.15
A panoramic view of yeast noncoding RNA processing. Cell (2003) 3.11
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing. Mol Cell (2008) 2.96
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood (2003) 2.73
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic (2010) 2.47
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
Methods for the detection and analysis of protein-protein interactions. Proteomics (2007) 2.29
The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22
Proteasome involvement in the repair of DNA double-strand breaks. Mol Cell (2004) 2.17
Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation (2007) 2.14
SpecAlign--processing and alignment of mass spectra datasets. Bioinformatics (2005) 2.13
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Hierarchical modularity and the evolution of genetic interactomes across species. Mol Cell (2012) 1.88
Ctf3p, the Mis6 budding yeast homolog, interacts with Mcm22p and Mcm16p at the yeast outer kinetochore. Genes Dev (2002) 1.88
Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75
Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation. Cell Stem Cell (2010) 1.74
Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity (2007) 1.73
Bioinformatic discovery of novel bioactive peptides. Nat Chem Biol (2007) 1.72
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J (2009) 1.71
Quantitative genetic-interaction mapping in mammalian cells. Nat Methods (2013) 1.68
Quantitative genetic interactions reveal biological modularity. Cell (2010) 1.64
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol (2007) 1.59
The protein expression of Streptococcus pyogenes is significantly influenced by human plasma. J Proteome Res (2005) 1.55
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat (2006) 1.53
Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat Struct Mol Biol (2012) 1.52
Structure and functional properties of the Bacillus subtilis transcriptional repressor Rex. Mol Microbiol (2008) 1.49
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun (2006) 1.47
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus. Front Genet (2013) 1.43
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health (2011) 1.39
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34
Measurement of Ca2+-binding constants of proteins and presentation of the CaLigator software. Anal Biochem (2002) 1.34
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
Calbindin D28k exhibits properties characteristic of a Ca2+ sensor. J Biol Chem (2002) 1.29
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Moderation of the platelet releasate response by aspirin. Blood (2007) 1.26
Residue-specific pKa determination of lysine and arginine side chains by indirect 15N and 13C NMR spectroscopy: application to apo calmodulin. J Am Chem Soc (2007) 1.25
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine (2013) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res (2006) 1.21
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20